Who Adopted The Resolution For Drug Development In Poor Countries

In the recently held 61 th World Health Assembly

, 190 countries from 2,704 delegates to participate in the discussion and adoption of a "public health, innovation and intellectual property," Global Strategy, namely to promote the treatment of common diseases in poor countries innovative drug plan, and strengthen access to drugs. It will provide a medium-term framework in order to strengthen and to sustain and diseases affecting developing countries, basic research and development.

That relate to "public health, innovation and intellectual property" strategy to encourage Governments to support the actual needs of developing countries, medicines, medical equipment, research and development as the goal. These are being ignored by big pharmaceutical companies, because they can not give big pharmaceutical companies to provide any profitable market opportunities. The plan includes incentive bonuses of drug development, and governments to purchase new drugs, vaccines and their commitment to the patent pool, the patentee can therefore use of patent pools to share each other's patented technology, so as to further provide a total platform of innovation. However, WHO Member States also need to plan the strategy of several key aspects of the relevant agreement, including financial needs, sources of funding and incentive mechanisms for innovation and new donations.

Public health activists after two years of tough negotiations to get the outcome agreed. Knowledge Ecology International Association of Amateur James that, WHO before the move to change the way people access to drugs means of innovation and the idea of a big step forward. MSF's Angerer called expert working group to continue to move forward boldly suggested the change in the way essential health R & D expenditure, as a diagnostic method for tuberculosis development incentive fund.

The same time, WHO's the strategy to strengthen the organization and the countries on IP issues related to public health advice role, structure plan for the future on the establishment of the global poor countries for the treatment of common diseases of drug research priorities order, and to lay the foundation for the discussion of research and development agreement.

It is understood that, although in recent years developing countries in the prevention, diagnosis and treatment of disease has made great progress, but basically still unable to benefit from modern science. The countries most affected people caught in a vicious cycle of poverty and disease among the face of life expectancy and economic recession and consequences. So how to make the poor people to facilitate access to health care products are the previous World Health Assembly resolutions. May 2006, Member States requested the World Health Organization (WHO) set up a "public health, innovation and intellectual property" of the Intergovernmental Working Group, its mandate is to develop a global strategy on essential health research and action plan for the treatment of severe diseases that affect developing countries, the resulting global plan of action to be submitted in mid-2008 to the World Health Assembly. The working group formed by the WHO Member States, in December 2006 held in Geneva 4-8 first meeting.

by: Frbiz

POST COMMENT

Details Acid Reflux Herbs - An Alternative Medicine Anti-drug Antibodies Medical Transcription Services: Dictation Continues To Be Most Efficient Way To Document A Patient Drug Rehabilitation In London Jinhua City Drug Chain Retail Chain Policies Help Achieve The 74% Rate Medical Errors - What You Need To Know Medical coding news: OIG Still Eyes Transforaminal Epidurals Can Acne Drugs And Antibiotics Make Your Acne Worse? Pharmaceutical Drug Contamination Of Waterways Threatens Life On Our Planet Traditional Chinese Medicine: principles of Traditional Chinese Medicine Why use drug? when pain can be cured drugless ! Aarkstore Enterprise - Top 10 Drug Delivery Technologies (2010 - 2015) Combination of Winstrol with other drugs